CA3 and diabetes mellitus: Consistent with the in vivo findings, our in vitro experiments revealed that a diabetes-mimicking environment led to a reduction in CAIII expression, which was alleviated by SP treatment (Supplementary Figures S2C,D, p < 0.05).